- Home
- ARVN vs ECX Comparison
ARVN vs ECX Comparison
Compare ARVN & ECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARVN | ECX |
|---|---|---|
| Founded | 2015 | 2017 |
| Country | United States | China |
| Employees | N/A | 1918 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 781.0M | 560.1M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARVN | ECX |
|---|---|---|
| Price | $12.48 | $1.15 |
| Analyst Decision | Buy | |
| Analyst Count | 21 | 0 |
| Target Price | ★ $15.71 | N/A |
| AVG Volume (30 Days) | 722.4K | ★ 6.0M |
| Earning Date | 05-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $262,600,000.00 | N/A |
| Revenue This Year | N/A | $819.09 |
| Revenue Next Year | N/A | $32.36 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.90 | $0.76 |
| 52 Week High | $14.22 | $3.07 |
Technical Indicators
Market Signals| Indicator | ARVN | ECX |
|---|---|---|
| Relative Strength Index (RSI) | 43.77 | 32.42 |
| Support Level | $11.07 | N/A |
| Resistance Level | $12.62 | $1.79 |
| Average True Range (ATR) | 0.79 | 0.21 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 47.81 | 5.63 |
Price Performance
Historical ComparisonAbout ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About ECX ECARX Holdings Inc. Ordinary shares
ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services in the People's Republic of China. The company's core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.